RISK FACTORS AND HYSTEROSCOPIC RESULTS FOR INSUFFICIENT TISSUE FROM ENDOMETRIAL BIOPSY

Aim: The aim of this study was to determine risk factors that may play a role in the diagnosis of insufficient endometrial tissue and toevaluate the office hysteroscopy findings of these patients.Materials and Methods: The clinical data and results of insufficient endometrial tissue in the medical records of patients at Bakırköy Dr.Sadi Konuk Teaching and Research hospital from August 2018 to November 2019 were analyzed retrospectively.Results: Endometrial biopsy procedures were applied to 1560 patients during the period evaluated for the study. The pathology report of81 patients (5.2%) was evaluated insufficient endometrial tissue. The results of the 64 patients were analyzed in the study. The meanage of the patients in the study was 52.1 years (range= 32-78 years). Results of 64 patients undergoing hysteroscopy; normalhysteroscopic findings (22 patients; 34%), endometrial polyp (18 patients; 28%), appearance of submucous myoma (6 patients; 10%)and atrophic endometrial appearance (18 patients; 28%) were evaluated.Conclusion: We point out that insufficient endometrial tissue diagnosis can be detected more often in postmenopausal cases over 60years of age and in patients with large uterine fibroids. Additionally, we emphasize that hysteroscopy can guide the clinician for definitivediagnosis in patients with insufficient endometrial tissue

Endometriyal Biyopsi Sonrası Yetersiz Doku Tanısının Olası Risk Faktörleri ve Histeroskopik Sonuçları

Amaç: Bu çalışmanın amacı yetersiz endometriyal doku tanısında rol oynayabilecek risk faktörlerini belirlemek ve bu hastaların ofis histeroskopi bulgularını değerlendirmektir. Materyal ve Metot: Ağustos 2018-Kasım 2019 tarihleri arasında Bakırköy Dr. Sadi Konuk Eğitim ve Araştırma hastanesinde yetersiz endometriyal doku tanılı hastaların klinik verileri ve sonuçları retrospektif olarak incelendi. Bulgular: Çalışma için değerlendirilen süre boyunca 1560 hastaya endometriyal biyopsi işlemleri uygulandı. 81 hastanın (% 5.2) patoloji raporu yetersiz endometriyal doku olarak değerlendirildi. Çalışma kriterleri eşliğinde 64 hastanın sonuçları analiz edildi. Çalışmadaki hastaların yaş ortalaması 52,1 (dağılım = 32-78) idi. Histeroskopi uygulanan 64 hastanın sonuçları; normal histeroskopik bulgular (22 hasta; % 34), endometriyal polip (18 hasta; % 28), submuköz miyom görünümü (6 hasta; % 10) ve atrofik endometriyal görünüm (18 hasta; % 28) olarak değerlendirildi. Sonuç: 60 yaşın üzerindeki postmenopozal olgularda ve büyük çaplı myomu olan hastalarda yetersiz endometriyal doku tanısının daha sık tespit edebileceğine dikkat çekmekteyiz. Ek olarak, histeroskopinin yetersiz endometriyal doku tanılı hastalarda uygun tanı için klinisyene rehberlik edebileceğini vurgulamaktayız.

PDF

___

1. Berek JS, Hacker NF. Berek and Hacker’s Gynecologic Oncology. 6th ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2010.

2. Chambers JT, Chambers SK. Endometrial sampling: When? Where? Why? With what? Clin Obstet Gynecol. 1992;35(1):28–39.

3. Shams G. Comparison of pipelle de cornier with conventional dilatation and curettage in terms of patients' acceptability. J Postgrad Med Inst. (Peshawar-Pakistan) 2012;26:418–21.

4. Gordon SJ, Westgate J. The incidence and management of failed pipelle sampling in a general outpatient clinic. Aust N Z J Obstet Gynaecol. 1999;39:115–8.

5. Sierecki AR, Gudipudi DK, Montemarano N, Del Priore G. Comparison of endometrial aspiration biopsy techniques: specimen adequacy. J Reprod Med. 2008;53(10):760–4.

6. Tanriverdi HA, Barut A, Gün BD, Kaya E. Is pipelle biopsy really adequate for diagnosing endometrial disease? Med Sci Monit. 2004;10(6):CR271–CR274.

7. Williams AR, Brechin S, Porter AJ, Warner P, Critchley HO. Factors affecting adequacy of pipelle and Tao Brush endometrial sampling. BJOG. 2008;115(8):1028–36.

8. Ronghe R, Gaudoin M. Women with recurrent postmenopausal bleeding should be re-investigated but are not more likely to have endometrial cancer. Menopause Int. 2010;16(1):9–11.

9. Larson DM, Broste SK. Histopathologic adequacy of office endometrial biopsies taken with the Z-sampler and Novak curette in premenopausal and postmenopausal women. J Reprod Med. 1994;39(4):300–3.

10. Bettocchi S, Ceci O, Di Venere R, Pansini MV, Pellegrino A, Marello F, et al. Advanced operative office hysteroscopy without anesthesia: analysis of 501 cases treated with a 5 fr. bipolar electrode. Hum Reprod. 2002;17(9):2435-438.

11. Harmanli OH, Shunmugham S, Shen T, Houck KL, Chatwani AJ. The negative predictive value of ‘’in adequate’’ endometrial biopsy in diagnosing endometrial neoplasia. J Gynecol Surg. 2004;20:13-6.

12. Gordon SJ, Westgate J. The incidence and management of failed pipelle sampling in a general outpatient clinic. Aust N Z J Obstet Gynaecol. 1999;39:115-8.

13. Clark TJ, Mann CH, Shah N, Song F, Khan KS, Gupta JK. Accuracy of outpatient endometrial biopsy in the diagnosis of endometrial cancer: a systematic qualitative review. BJOG. 2002;109:313-21.

14. Bakour SH, Khan KS, Gupta JK. Controlled analysis of factors associated with insufficient sample on outpatient endometrial biopsy. BJOG. 2000;107(10):1312–314.

15. van Doorn HC, Opmeer BC, Burger CW, Duk MJ, Kooi GS, Mol BWJ, et al. Inadequate office endometrial sample requires further evaluation in women with post-menopausal bleeding and abnormal ultrasound results. Int J Gynaecol Obstet. 2007;99(2):100–104.

16. Xie B, Qian C, Yang B, Ning C, Yao X, Du Y, et al. Risk Factors for Unsuccessful Office- Based Endometrial Biopsy: A Comparative Study of Office-Based Endometrial Biopsy (Pipelle) and Diagnostic Dilation and Curettage. J Minim Invasive Gynecol. 2018;25(4):724–29.

17. Visser NC, Breijer MC, Herman MC, Bekkers RLM, Veersema S, Opmeer BC, et al. Factors attributing to the failure of endometrial sampling in women with postmenopausal bleeding. Acta Obstet Gynecol Scand. 2013;92(10):1216–1222.

18. Kandil D, Yang X, Stockl T, Liu Y. Clinical outcomes of patients with insufficient sample from endometrial biopsy or curettage. Int J Gynecol Pathol. 2014;33(5):500–6.

19. Adambekov S, Goughnour SL, Mansuria S, Donnellan N, Elishaev E, Villanueva HJ, et al. Patient and provider factors associated with endometrial Pipelle sampling failure. Gynecol Oncol. 2017;144(2):324–28.

20. Cancer Australia. Abnormal vaginal bleeding in pre- and peri-menopausal women: a diagnostic guide for general practitioners and gynaecologists. Surry Hills: Cancer Australia;2011.

21. SOGC clinical practice guideline No. 86. Diagnosis of endometrial cancer in women with abnormal vaginal bleeding. J Soc Obstet Gynaecol Can. 2000;22:102-4.

22. Youssif SN, McMillian DL. Outpatient endometrial biopsy: the pipelle. Br J Hosp Med. 1995;54(5):198-201.

23. Aue-Aungkul A, Kleebkaow P, Kietpeerakool C. Incidence and risk factors for insufficient endometrial tissue for endometrial sampling. Int J Womens Health. 2018;10:453-457.

24. Yarandi F, Izadi-Mood N, Eftekhar Z, Shojaei H, Sarmadi S.